Shares of Dishman Pharmaceuticals and Chemicals may see buying interest on Tuesday on positive outlook from a rating agency.
The pharma major informed the bourses that India Rating and Research Pvt Ltd has revised the outlook to ‘positive’ from ‘stable’ for its long-term/fund-based facilities and non-convertible debenture issues. It has, however, reaffirmed its rating at ‘Ind A’ for (term loans & NCDs) and ‘Ind A1’ for short-term facilities
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.